The estimated Net Worth of John Goll is at least $3.18 millió dollars as of 18 November 2019. John Goll owns over 25,000 units of Insmed Inc stock worth over $2,351,749 and over the last 5 years he sold INSM stock worth over $0. In addition, he makes $832,283 as Chief Accounting Officer at Insmed Inc.
John has made over 1 trades of the Insmed Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of INSM stock worth $314,500 on 18 November 2019.
The largest trade he's ever made was exercising 25,000 units of Insmed Inc stock on 18 November 2019 worth over $314,500. On average, John trades about 12,500 units every 0 days since 2019. As of 18 November 2019 he still owns at least 32,322 units of Insmed Inc stock.
You can see the complete history of John Goll stock trades at the bottom of the page.
John Goll is the Chief Accounting Officer at Insmed Inc.
As the Chief Accounting Officer of Insmed Inc, the total compensation of John Goll at Insmed Inc is $832,283. There are 6 executives at Insmed Inc getting paid more, with William Lewis having the highest compensation of $7,175,090.
John's mailing address filed with the SEC is 700 US HIGHWAY 202/206, , BRIDGEWATER, NJ, 08807.
Over the last 22 years, insiders at Insmed Inc have traded over $46,121,705 worth of Insmed Inc stock and bought 1,080,212 units worth $8,226,993 . The most active insiders traders include Llc Fmr, William Lewis és Dennis M Lanfear. On average, Insmed Inc executives and independent directors trade stock every 38 days with the average trade being worth of $2,452,158. The most recent stock trade was executed by Orlov S Nicole Schaeffer on 10 September 2024, trading 37,575 units of INSM stock currently worth $407,689.
insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.
Insmed Inc executives and other stock owners filed with the SEC include: